Skip to the page

Data / Drug companies / Sodium bicarbonate

Sodium bicarbonate: 51 companies and 89 products in the FDA NDC directory

Sodium bicarbonate is listed in the FDA National Drug Code Directory by 51 companies, with 89 products in commercial distribution. 37 of the products (41.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; tablet; powder, and the newest product started marketing on August 14, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
51
Products
89
Generic (ANDA) products
37 (41.6%)
Application numbers
19
Routes
Intravenous, Oral, Topical
Brand names
Ahhh Bite Relief, After Bite X Tech, DR. Sana Bicarbonato de Sodio 4 Fl Oz and 6 Floz, Anti-Empacho, D-D Sudium Bicarbonate U.s.p. Bicarbonato de Soda Puro, After Bite Kids, Insect Sting Relief Pad 01, Insect Sting Relief Latex 01
openFDA record search
api.fda.gov

Companies that list sodium bicarbonate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Exela Pharma Sciences, LLC6injection, solutionGeneric drugs (ANDA)September 1, 2020
Medical Purchasing Solutions, LLC6injection, solution; injectionGeneric drugs (ANDA)August 7, 2025
HF Acquisition Co LLC, DBA HealthFirst5injection, solution; injectionOther unapproved drugsFebruary 18, 2022
Hospira, Inc.5injection, solutionGeneric drugs (ANDA)March 1, 2021
Evi Labs4powderOver the counter monograph drugsJanuary 28, 2026
Tender Corporation D/B/A Adventure Ready Brands4liquid; creamOver the counter monograph drugsJune 17, 2025
Twin Med LLC3tabletOver the counter monograph drugsMarch 1, 2026
A-S Medication Solutions2injection, solutionGeneric drugs (ANDA)March 1, 2021
Amneal Pharmaceuticals Private Limited2injection, solutionGeneric drugs (ANDA)July 13, 2026
Citragen Pharmaceuticals Inc2tabletOver the counter monograph drugsApril 20, 2018
Cosmuses Cosmetics (Ningbo) Co., Ltd.2cloth; lotionOver the counter monograph drugsJune 14, 2024
DLC Laboratories, Inc.2powder; liquidOver the counter monograph drugsMarch 15, 2016
Fresenius Kabi USA, LLC2injection, solutionGeneric drugs (ANDA)August 25, 2025
Henry Schein, Inc.2injection, solutionGeneric drugs (ANDA)January 12, 2022
Lotus Brands, Inc.2liquidOver the counter monograph drugsJune 1, 2013
Menper Distributors, Inc.2liquid; powderOver the counter monograph drugsJanuary 1, 2017
ProPharma Distribution2injection, solution; injectionGeneric drugs (ANDA)March 15, 2024
Richmond Pharmaceuticals, Inc.2tabletOver the counter monograph drugsJune 1, 2015
Rugby Laboratories2tabletOver the counter monograph drugsMarch 25, 2015
782711gelOver the counter monograph drugsOctober 29, 2024
Advanced Rx LLC1tabletOver the counter monograph drugsSeptember 1, 2025
Anthea Pharma Private Limited1injection, solutionGeneric drugs (ANDA)June 26, 2025
Aphena Pharma Solutions - Tennessee, LLC1tabletOver the counter monograph drugsMarch 25, 2015
Aphena Pharma Solutions - Tennessee, LLC1tabletOver the counter monograph drugsMay 1, 2015
Apnar Pharma LP1tabletOver the counter monograph drugsJune 24, 2022
Baxter Healthcare Corporation1injection, solutionNew drug applications (NDA)August 14, 2026
Bryant Ranch Prepack1tabletOver the counter monograph drugsJuly 20, 2020
Bryant Ranch Prepack1injection, solutionGeneric drugs (ANDA)June 16, 2023
Cardinal Health 107, LLC1tabletOver the counter monograph drugsOctober 26, 2022
Church & Dwight Co., Inc.1powderOver the counter monograph drugsJanuary 1, 2000
Civica, Inc.1injection, solutionGeneric drugs (ANDA)August 1, 2019
Gendose Pharmaceuticals, LLC1tabletOver the counter monograph drugsMay 1, 2026
Glenmark Pharmaceuticals Inc., USA1injection, solutionGeneric drugs (ANDA)August 7, 2025
Graxcell Pharmaceutical, LLC1tabletOver the counter monograph drugsOctober 2, 2017
Humco Holding Group, Inc1powderOver the counter monograph drugsNovember 9, 2017
Humco Holding Group, Inc.1powderOver the counter monograph drugsMarch 25, 1998
International Medication Systems, Limited1injectionGeneric drugs (ANDA)June 1, 2000
Major Pharmaceuticals1tabletOver the counter monograph drugsOctober 26, 2022
Milla Pharmaceuticals Inc.1injection, solutionGeneric drugs (ANDA)August 7, 2026
NCS HealthCare of Ky, LLC DBA Vangard Labs1tabletOver the counter monograph drugsMarch 25, 2015
Omnivium Pharmaceuticals LLC.1injection, solutionGeneric drugs (ANDA)June 16, 2023
Pharma Nobis, LLC1powderOver the counter monograph drugsOctober 27, 2017
Pharmadel LLC1powderOver the counter monograph drugsNovember 23, 2020
Reliable 1 Laboratories LLC1tablet, solubleOver the counter monograph drugsNovember 1, 2015
Remedyrepack Inc.1injectionGeneric drugs (ANDA)August 14, 2024
Rising Pharma Holdings, Inc.1tabletOver the counter monograph drugsJuly 20, 2020
Steriscience Specialties Private Limited1injection, solutionGeneric drugs (ANDA)March 8, 2024
Sun Pharmaceutical Industries, Inc.1injection, solutionGeneric drugs (ANDA)March 15, 2024
Vitamex USA, Corp1powderOver the counter monograph drugsMay 1, 2026
Westminster Pharmaceuticals, LLC1tabletOver the counter monograph drugsOctober 10, 2022
World Perfumes Inc1powderOver the counter monograph drugsFebruary 5, 2020

Dosage forms

Dosage formProductsShare
Injection, solution3842.7%
Tablet2123.6%
Powder1314.6%
Liquid66.7%
Injection55.6%
Cream22.2%
Gel11.1%
Tablet, soluble11.1%
Cloth11.1%
Lotion11.1%

Marketing categories

Marketing categoryProductsShare
Over the counter monograph drugs4651.7%
Generic drugs (ANDA)3741.6%
Other unapproved drugs44.5%
New drug applications (NDA)22.2%

Pharmacologic classes

ClassProducts
Osmotic Laxative41

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.